Por: New York Daily News Nation July 18, 2023
Pharma behemoth Eli Lilly & Co. says the experimental drug donanemab, which can slow cognitive decline in Alzheimer’s patients by months during early stages of the disease, showed efficacy in a late-stage clinical trial. While it appears more effective than other treatments, the experimental drug can cause the brain to swell or bleed, the drugmaker said in its presentation to the Alzheimer’s Association International Conference in Amsterdam... + full article
The Advocate USA Health May 01, 2023
What are the latest statistics about Alzheimer’s disease?According to the newly released 2023 Alzheimer’s Association Facts and Figures, an estimated 6.7 million Americans aged 65 and older are living with Alzheimer’s.Seventy-three percent are age 75 or older. About one in... + más
How To Spot The Early Signs Of Alzheimer's | Newsweek
Here's what disease does to brain, signs to look for: Alzheimer's Q&A | The Advocate
The Advocate USA Health January 02, 2023
What is Alzheimer’s disease?German neurologist Dr. Alois Alzheimer first identified this neurological disorder in 1906 while studying the pathology of a woman he had treated for an unusual mental illness.While examining her brain after her death, Alzheimer noticed marked... + más
Reimagining Alzheimer’s (Part 4): Cautious Optimism For A New Alzheimer’s Disease Treatment | Forbes
Forbes USA Tech December 05, 2022
A recent paper published in Nature reveals a new mechanism by which the genetic risk factor APOE4 ... [+] may cause Alzheimer's symptoms.American Society of Human Genetics, Allen School of Health Sciences This article is the sixth installment in my series on Alzheimer’s... + más
A Promising Trial Targets a Genetic Risk for Alzheimer’s | The New York Times
Chris Hemsworth discovers he may be at risk for Alzheimer’s disease in new series, ‘Limitless’ | ABC News
The Advocate USA Health November 16, 2022
Are U.S. veterans more at risk for Alzheimer’s or other dementias?The U.S. is in the midst of a dramatic rise in the number of veterans with Alzheimer’s disease and other dementias, and many of these new cases are directly attributable to military service.According to a 2017... + más
Stroke can lead to vascular dementia: Alzheimer's Q&A | The Advocate
Forbes USA Tech October 22, 2022
A person walks on a suspended rope bridge in the clouds. Extreme attraction.getty This article is the fourth installment in my series on Alzheimer’s disease. Read more about Alzheimer’s disease in , , and of the series. The pharmaceutical and biotech companies, Eisai and... + más
COVID-19 in seniors linked to increased Alzheimer’s risk, study finds | Portland Press Herald
Variety of factors play a role in the development of Alzheimer's | The Advocate
Newsweek USA Health September 24, 2022
The Alzheimer's Association defines Alzheimer's as a brain disease that causes a slow decline in memory, thinking and reasoning skills. Dementia refers to the symptoms of Alzheimer's that can worsen over time.They predict that by 2050, the number of people aged 65... + más
There's a growing dementia crisis in the veteran community: Alzheimer's Q&A | The Advocate
Portland Press Herald USA Health September 24, 2022
A study using the electronic health records of more than 6 million Americans over age 65 found that those who had COVID-19 ran a greater risk of receiving a new diagnosis of Alzheimer’s disease within a year. The study, led by researchers at Case Western Reserve University... + más
About iurex | Privacy Policy | Disclaimer |